Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × irinotecan sucrosofate × 90 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 3 Biliary Tract Neoplasms 3 Osteosarcoma 2 Neoplasms 2 Wilms Tumor 1 Stomach Neoplasms 1 Small Bowel Adenocarcinoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasm Metastasis 1 Metastatic Adenocarcinoma of the Pancreas 1 Malignant Ascites 1 Hepatoblastoma 1 Gastrointestinal Neoplasms 1 Colorectal Cancer Metastatic 1 Advanced Colorectal Cancer 1

Interventions

pembrolizumab 41 Carboplatin 22 Paclitaxel 21 Specimen Handling 16 Biopsy 14 Magnetic Resonance Spectroscopy 13 Cyclophosphamide 12 Capecitabine 10 130-nm albumin-bound paclitaxel 9 olaparib 8 Doxorubicin 8 Albumin-Bound Paclitaxel 8 Gemcitabine 7 eribulin 6 sacituzumab govitecan 5 Taxes 5 Bevacizumab 5 toripalimab 4 atezolizumab 4 Standard of Care 4 Nivolumab 4 Injections 4 Drug Therapy 4 Docetaxel 4 liposomal doxorubicin 3 durvalumab 3 capivasertib 3 X-Rays 3 Radiation 3 Platinum 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡